. 2021 Jul 19;36(2):249–255. doi: 10.1177/08971900211033138
© The Author(s) 2021
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
Figure 2.
TOF assessments for the first 5-day of infusion.